Category: TRENDS IN THE VACCINE ROLLOUT

Despite the fact that the COVID-19 vaccines in circulation were rushed into use through the Emergency Use Authorization Act and are using a new type of mRNA encoding technology, The New York Times published an article on 12 February with the headline:  As Millions Get Shots, F.D.A. Struggles to Get Safety Monitoring System Running At the...

Many states in the U.S. approached rates of 20,000 vaccinations per 100,000 in population this past week. States with the highest levels of vaccination included Virginia, West Virginia, Maine, North and South Dakota, Vermont, Connecticut, Oklahoma, Arkansas, Colorado, Oregon, and Alaska. States with low levels of vaccine takers included Idaho, Missouri, Iowa, Kansas, Mississippi, and...

Facebook announced yesterday it will dish out $120 million in free advertising to health departments and non-government organizations that promote getting tested for COVID and getting vaccinated.  For those who dispute the efficacy of the tests and the safety of the vaccine, the world’s largest social media network said they will censor and banish all who...

The U.K.’s National Health Service (NHS) found that about one in three who received the COVID vaccine reported some kind of side effect, the BBC reported… but this was barely reported in the western media and was in and out of the news. The most common was soreness around the site of the Pfizer-BioNTech injection. There were...

For anyone who thought the availability of a COVID vaccine or “herd immunity” would lead to a return to anything like normal life in America, guess again. In a recent press conference, President Biden’s press secretary placed no time frame on precautions that many say are devastating the country more than the virus itself. Spokesperson...

In our 5 January Trends Journal, we reported a survey by the American Nurses Foundation found that “nearly half (44 percent) of nurses say they are not comfortable having conversations with their patients about COVID-19 vaccines.” (See our article, “MASSIVE VACCINATION CAMPAIGN.”) Now, a New Yorker article published on 2 February documents how many health...

French President Emmanuel Macron said Thursday there are lingering questions about the Chinese vaccine, and he even suggested that an ineffective vaccine could help develop a new virus variant. Macron said there has been “no information” about the trials of the vaccine from Sinopharma and Sinovac. Fortune magazine reported that neither company published its Phase III trial...

Switzerland announced last week that it would not administer the Oxford/AstraZeneca COVID-19 vaccine because the data “available and evaluated to date [is] not yet sufficient,” the country’s health agency said. The Financial Times reported there have been concerns about the effectiveness of the shot with people above 65, and countries such as Sweden and Germany have advised...

Last Thursday, the website of Medscape.com contained an interview conducted last fall with Dr. Paul Alan Offit, Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania and former chief of the Division of Infectious Diseases (1992–2014). Some of the key points he made included: “It’s all happening at warp speed,...

On 29 January, the coronavirus vaccine developed by AstraZeneca and the University of Oxford was approved by Europe’s drug regulator, the European Medicines Agency (EMA). It was first used in the U.K. As reported on CNBC at that time, the executive director of the EMA said, “With this third positive opinion, we have further expanded the arsenal...